Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: Patient Educ Couns. 2019 May 18;102(10):1882–1891. doi: 10.1016/j.pec.2019.05.005

Appendix Table 2.

Pairwise Comparisons by Treatment Group at 18 Monthsa

Established vs. Advice Only Mean (95% CI) P-Value Established + DASH vs. Advice Only Mean (95% CI) P-Value Established + DASH vs. Established Mean (95% CI) P-Value
LDL Cholesterol (mg/dL)
 All −2.0 (−5.3 to 1.4) .25 1.1 (−2.4 to 4.6) .54 3.1 (−0.7 to 6.8) .11
 LDL ≥ 130 mg/dL −5.0 (−10.1 to 0.0) .05 −0.7 (−5.6 to 4.2) .79 4.4 (−1.2 to 9.9) .12
 LDL < 130 mg/dL 1.3 (−3.1 to 5.6) .56 3.4 (−1.6 to 8.4) .18 2.1 (−3.0 to 7.2) .42

HDL Cholesterol (mg/dL)
 All 1.5 (0.3 to 2.8) .01 0.7 (−0.4 to 1.8) .19 −0.8 (−2.1 to 0.4) .19
 HDL ≥ 40 mg/dL (Male) and 50 mg/dL (Female) 1.4 (−0.5 to 3.3) .16 −0.2 (−1.9 to 1.5) .84 −1.5 (−3.5 to 0.5) .13
 HDL < 40 mg/dL (Male) and 50 mg/dL (Female) 1.7 (0.2 to 3.2) .02 1.8 (0.3 to 3.2) .01 0.03 (−1.4 to 1.5) .97

Triglycerides (mg/dL)
 All −7.0 (−15.9 to 1.9) .12 −3.2 (−13.5 to 7.0) .53 3.8 (−5.7 to 13.3) .44
 Triglyceride ≥ 200 mg/dL −17.7 (−58.7 to 23.2) .39 −16.0 (−61.4 to 29.5) .49 1.8 (−36.0 to 39.6) .93
 Triglyceride < 200 mg/dL −5.7 (−12.3 to 1.0) .09 −0.7 (−8.0 to 6.6) .85 5.0 (−2.5 to 12.6) .19

Total Cholesterol (mg/dL)
 All −1.5 (−5.3 to 2.2) .42 1.9 (−2.9 to 4.9) .62 2.5 (−1.6 to 6.7) .23
 Total Cholesterol ≥ 240 mg/dL −3.1 (−13.6 to 7.5) .57 −0.8 (−12.2 to 10.7) .90 2.3 (−9.1 to 13.7) .69
 Total Cholesterol < 240 mg/dL −1.1 (−5.1 to 2.9) .58 1.5 (−2.6 to 5.5) .47 2.6 (−1.8 to 7.0) .24
a

Data are presented as mean difference (95% Confidence Interval) unless otherwise indicated